Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial

Treatment-resistant schizophrenia (TRS) is a prevalent clinical problem with heterogeneous presentations. However, the clinical trial designs for new treatments are still lacking. This study aimed to assess the efficacy of ziprasidone plus sertraline in TRS patients as compared to ziprasidone monoth...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Hui Shi, Jing Xu, Xiaoe Lang, Hanjing Emily Wu, Mei Hong Xiu, Xiang Yang Zhang
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2022-04-01
Serija:Frontiers in Pharmacology
Teme:
treatment-resistant
ziprasidone
sertraline
efficacy
schizophrenia
acute exacerbation
Online dostop:https://www.frontiersin.org/articles/10.3389/fphar.2022.863588/full
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki